Arnold Silverberg
Orthopaedic Surgery · Clyde, NCNPI 1629463070
Payments from drug & device makers
Across 64 payments — averaging $120.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$7K
- Stryker$325
- Ortho Development Corporation$124
- Medical Device Business Services, Inc.$99
- Tactile Systems Technology Inc$92
- Pacira Pharmaceuticals Incorporated$59
- plus $234 from 10 others
What the payments were for
- Travel & lodging$4,66360%
- Food & beverage$3,07440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 42 | $6,805 |
| Stryker | 3 | $325 |
| Ortho Development Corporation | 1 | $124 |
| Medical Device Business Services, Inc. | 1 | $99 |
| Tactile Systems Technology Inc | 4 | $92 |
| Pacira Pharmaceuticals Incorporated | 2 | $59 |
| Vertex | 2 | $54 |
| Orthofix Medical, Inc. | 1 | $28 |
| Avanos Medical | 1 | $28 |
| Bioventus LLC | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Kerecis Limited | 1 | $19 |
| KCI USA, Inc. | 1 | $19 |
| Medtronic | 1 | $17 |
| Linvatec Corporation | 1 | $14 |
| Heraeus Medical, LLC. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REAL INTELLIGENCE$4,104
- Legion Revision$2,456
- OR3O Dual Mobility$1,168
- REDAPT$1,146
- JOURNEY$1,024
- Firstpass$874
- ACUFEX Meniscal Root Repair$874
- VISIONAIRE$580
- POLARSTEM$580
- Journey II XR$371
- R3$371
- CORI$263
- Journey II$259
- Journey II CR$209
- GAMMA$139
- Balanced Knee Revision System$124
- MAKO$100
How this compares
$7,737 in reported general payments places this provider in the 55th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 240 | $3,597 |
| Ondansetron OdtOndansetron | 256 | $2,970 |
| Doxycycline Hyclate | 196 | $2,387 |
| Oxycodone Hcl | 354 | $1,728 |
| Ampicillin Sodium | 15 | $1,545 |
| Mupirocin | 246 | $1,338 |
| Diclofenac Sodium | 78 | $518 |
| Cyclobenzaprine Hcl | 60 | $261 |
| Cefadroxil | 22 | $257 |
| Amoxicillin | 57 | $148 |
| Tramadol Hcl | 53 | $130 |
| Gabapentin | 24 | $124 |
| Prednisone | 39 | $69 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $61 |
| Clindamycin Hcl | 18 | $57 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Clyde
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$6.2M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$5.2M
- Mark EasleyDurham$4.2M
- Carroll JonesCharlotte$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.